At close: November 22 at 4:00 PM EST
After hours: 7:59 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Nov 2024) | Next Qtr. (Feb 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 17 | 16 |
| Avg. Estimate | 0.39 | 0.53 | 1.58 | 1.58 |
| Low Estimate | 0.33 | 0.47 | 1.42 | 1.14 |
| High Estimate | 0.53 | 0.65 | 2.1 | 2.45 |
| Year Ago EPS | 0.66 | 1.2 | 2.88 | 1.58 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Nov 2024) | Next Qtr. (Feb 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 16 | 15 |
| Avg. Estimate | 37.33B | 37.57B | 148.96B | 151.66B |
| Low Estimate | 36.62B | 36.85B | 146.13B | 146.77B |
| High Estimate | 38.17B | 38.51B | 151.99B | 158.27B |
| Year Ago Sales | 36.71B | 37.05B | 147.66B | 148.96B |
| Sales Growth (year/est) | 1.71% | 1.39% | 0.88% | 1.81% |
Earnings History
| CURRENCY IN USD | 11/30/2023 | 2/29/2024 | 5/31/2024 | 8/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.62 | 0.82 | 0.71 | 0.36 |
| EPS Actual | 0.66 | 1.2 | 0.63 | 0.39 |
| Difference | 0.04 | 0.38 | -0.08 | 0.03 |
| Surprise % | 6.44% | 45.75% | -11.03% | 9.39% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Nov 2024) | Next Qtr. (Feb 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.39 | 0.53 | 1.58 | 1.58 |
| 7 Days Ago | 0.4 | 0.54 | 1.58 | 1.6 |
| 30 Days Ago | 0.41 | 0.55 | 1.61 | 1.66 |
| 60 Days Ago | 0.47 | 0.61 | 1.91 | 2.13 |
| 90 Days Ago | 0.49 | 0.63 | 2.08 | 2.31 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Nov 2024) | Next Qtr. (Feb 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 3 | 5 | 3 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | 5 | 2 | 9 | 7 |
Growth Estimates
| CURRENCY IN USD | WBA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -40.95% | -- | -- | 5.00% |
| Next Qtr. | -55.66% | -- | -- | 12.00% |
| Current Year | -45.19% | -- | -- | 2.10% |
| Next Year | 0.14% | -- | -- | 12.20% |
Top Analysts Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn More
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn MoreAnalyst | Overall Score | Direction Score | Price Score | Latest Rating | Price Target | Date |
|---|---|---|---|---|---|---|
| B of A Securities | 58 | 53 | 78 | Underperform | 7.5 | 9/5/2024 |
| Morgan Stanley | 54 | 53 | 87 | Underweight | 7 | 10/12/2024 |
| UBS | 47 | 35 | 84 | Neutral | 10 | 10/17/2024 |
| TD Cowen | 41 | 11 | 98 | Buy | 14 | 10/23/2024 |
| Jefferies | 35 | 25 | 70 | Hold | 9 | 10/23/2024 |
| Barclays | 35 | 12 | 99 | Underweight | 8 | 10/17/2024 |
| Truist Securities | 35 | 9 | 99 | Hold | 10 | 10/8/2024 |
| RBC Capital | 32 | 7 | 99 | Sector Perform | 13 | 7/3/2024 |
| Deutsche Bank | 31 | 7 | 99 | Hold | 22 | 4/3/2024 |
| JP Morgan | 30 | 10 | 97 | Overweight | 15 | 8/30/2024 |
Rows per page
1-10 of 12
Upgrades & Downgrades
| Maintains | Jefferies: Hold to Hold | 10/23/2024 |
| Maintains | TD Cowen: Buy to Buy | 10/22/2024 |
| Maintains | UBS: Neutral to Neutral | 10/17/2024 |
| Maintains | Barclays: Underweight to Underweight | 10/16/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 10/16/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 10/11/2024 |
Related Tickers
PETS PetMed Express, Inc.
4.7800
+3.02%
HITI High Tide Inc.
2.6500
-0.75%
RADLY Raia Drogasil S.A.
4.8030
0.00%
HITI.V High Tide Inc.
3.7000
-0.27%
PINK.PR Pilulka Lékárny a.s.
129.50
0.00%
CJJD China Jo-Jo Drugstores, Inc.
2.0017
+2.13%
BIMI BIMI Holdings Inc.
0.0100
0.00%
4164.SR Nahdi Medical Company
118.60
-1.00%
6618.HK JD Health International Inc.
27.300
-4.55%
0241.HK ALI HEALTH
3.550
-5.59%